How would you spend $13 billion in cash? Is biotech stale? And remember Dendreon?
We include all that and extra this week on “The Readout LOUD,” STAT’s biotech podcast. We talk about a multibillion-greenback deal from Vertex Prescribed drugs with sweeping implications and a lengthy backstory. We also demonstrate why fuel selling prices are weighing on biotech, and make a surprise announcement.
Browse the rest…